Stocks and Investing Stocks and Investing
Wed, February 22, 2023
[ 12:00 AM ] - WOPRAI
Stephen Byrd Maintained (SRE) at Hold with Decreased Target to $79 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Josh Beck Maintained (SQ) at Buy with Increased Target to $100 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (STR) at Buy with Decreased Target to $30 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (TGT) at Buy with Increased Target to $205 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Maintained (TAP) at Sell with Increased Target to $49 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (TAP) at Sell with Increased Target to $48 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Kyle Peterson Maintained (ALIT) at Strong Buy with Increased Target to $13 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Maintained (ALIT) at Buy with Increased Target to $16 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
John Heagerty Downgraded (AIG) to Hold and Decreased Target to $65 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (AKBA) at Hold and Held Target at $1.25 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Steven Cahall Maintained (AMCX) at Sell with Increased Target to $15 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jay McCanless Maintained (TPH) at Buy with Increased Target to $27 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Tate Sullivan Upgraded (TOPS) to Strong Buy and Held Target at $30 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Bill Katz Reiterated (TPG) at Hold and Held Target at $36 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Keith Hughes Downgraded (TILE) to Hold and Decreased Target to $9 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Simeon Siegel Maintained (TJX) at Buy and Held Target at $85 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Scott Fidel Maintained (THC) at Hold with Increased Target to $64 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Justin Long Maintained (TRN) at Hold with Decreased Target to $26 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Allison Poliniak Cusic Maintained (TRN) at Buy with Decreased Target to $30 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Bora Lee Maintained (UNIT) at Hold with Decreased Target to $7 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Reiterated (UBER) at Buy and Held Target at $45 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Ariel Rosa Maintained (UPS) at Buy and Held Target at $206 on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Jim Sanderson Downgraded (TXRH) to Hold on, Feb 22nd, 2023
[ 12:00 AM ] - WOPRAI
Edward Nash Maintained (TVTX) at Strong Buy with Increased Target to $44 on, Feb 22nd, 2023
Tue, February 21, 2023
[ 12:00 AM ] - WOPRAI
Derrick Whitfield Initiated (txo) at Strong Buy and Held Target at $31 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
John Freeman Initiated (txo) at Strong Buy and Held Target at $34 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Phillips Johnston Initiated (txo) at Buy and Held Target at $35 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Siti Panigrahi Maintained (TWLO) at Strong Buy with Increased Target to $90 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Ed Arce Reiterated (TVTX) at Strong Buy with Increased Target to $40 on, Feb 21st, 2023
[ 12:00 AM ] - WOPRAI
Carter Gould Maintained (TVTX) at Buy with Decreased Target to $31 on, Feb 21st, 2023

Carter Gould Maintained (TVTX) at Buy with Decreased Target to $31 on, Feb 21st, 2023


Published on 2024-10-28 01:46:55 - WOPRAI, Carter Gould
  Print publication without navigation


Carter Gould of Barclays, Maintained "Travere Therapeutics, Inc." (TVTX) at Buy with Decreased Target from $37 to $31 on, Feb 21st, 2023.

Carter has made no other calls on TVTX in the last 4 months.



There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 1 agrees with Carter's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Alex Thompson of "Stifel" Initiated at Hold and Held Target at $22 on, Wednesday, December 14th, 2022


This is the rating of the analyst that currently disagrees with Carter

  • Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $40 on, Monday, January 30th, 2023
Contributing Sources